August 2026
The intravenous immunoglobulin market size reached USD 7.80 billion in 2026, with leading intravenous immunoglobulin market companies including Octapharma AG, CSL Behring, Grifols SA.
September 2026
The global anti-D immunoglobulin market size is estimated to hit around USD 5.85 billion by 2035 increasing from USD 3.61 billion in 2026, with a CAGR of 5.51%.
September 2026
The global immunoglobulin market size is anticipated to hit around USD 30.62 billion by 2035 from USD 15.35 billion in 2025 with a CAGR.
June 2026
The global intravenous equipment market size was calculated at USD 23.94 billion in 2025 and is projected to attain around USD 42.61 billion by 2035 with a CAGR of 6.26%
March 2026
The global intravenous iron drugs market size was valued at USD 3.84 billion in 2025 and is expected to attain around USD 8.82 billion by 2035 at a CAGR of 8.67%.
March 2026
The global intravenous infusion pump market size is estimated to hit around USD 14.81 billion by 2035 increasing from USD 6.72 billion in 2025, with a CAGR of 8.22%.
February 2026
The subcutaneous immunoglobulin market size was estimated at USD 17.97 billion in 2025 and is projected to surpass around USD 37.12 billion by 2035, with a CAGR of 7.52%.
August 2025
The intravenous (IV) hydration therapy market size reached USD 2.71 billion in 2024 and is projected to surpass around USD 5.84 billion by 2034, with a notable CAGR of 7.98%.